Xvivo Perfusion AB (OTCPK:XVIPF)
$ 42.9 1.67 (4.05%) Market Cap: 1.38 Bil Enterprise Value: 1.34 Bil PE Ratio: 67.14 PB Ratio: 7.03 GF Score: 86/100

Q2 2022 Xvivo Perfusion AB Earnings Call Transcript

Jul 13, 2022 / 12:00PM GMT
Release Date Price: $21.8
Operator

Ladies and gentlemen, welcome to the XVIVO Group's Interim Report Q2 2020. I will now hand over to Dag Andersson, CEO. Sir, please go ahead.

Dag Andersson;publ;President;CEO
Xvivo Perfusion AB

()-&

Thank you very much. So Dag Andersson and Kristoffer Nordstrom here in Gothenburg to present the Q2 numbers and our main event. You can see here on the front page of the interim report, you can see a picture actually over Gothenburg with a lady or woman named [Frederica], who just received a new liver. And she is, of course, very happy with that. And she's actually featuring in several of our media and communications right now.

So we will then start by talking a little bit about Q2 financials at a glance as we call it. We have delivered a strong quarter or let's say, yet another strong quarter. And when I say strong, I refer to both sales, gross margins and profitability. We are actually getting closer to delivering our first quarter with SEK 100 million in sales. We're not far away from that, which is very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot